Qiagen NV (QGEN)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $10.29B
Last updated: Nov 17, 2026 at 4:10 PM ET
Qiagen NV (QGEN) Stock Chart
Qiagen NV (QGEN) has a latest price of $49.75 on Nov 17, 2026, 13.2% below its 52-week high of $57.30. Its price rose 11.7% over the past 12 months. The month-end price rose 106.0% over the 10 years through Oct 2026, a compound annual rate of 7.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $55.82 in Aug 2021 and its lowest $24.38 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart QGEN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for QGEN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 11.8%, and over 6 months it rose 46.6%. The month-end price rose 34.2% over the 3 years through Oct 2026, a compound annual rate of 10.3%.
| Period | Change |
|---|---|
| 1 month | +6.9% |
| 3 months | +11.8% |
| 6 months | +46.6% |
| 12 months | +11.7% |
| 12 months, with dividends | +17.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +34.2% | +10.3% |
| 5 years | -9.9% | -2.1% |
| 10 years | +106.0% | +7.5% |
Price by Year
Its best calendar year was 2020, when the price rose 56.4%, and its weakest was 2023, when it fell 12.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $50.22 | +11.7% |
| 2025 | $44.97 | +1.0% |
| 2024 | $44.53 | +2.5% |
| 2023 | $43.43 | -12.9% |
| 2022 | $49.87 | -10.3% |
| 2021 | $55.58 | +5.2% |
| 2020 | $52.85 | +56.4% |
| 2019 | $33.80 | -1.9% |
| 2018 | $34.45 | +11.4% |
| 2017 | $30.93 | +10.4% |
Trading Range
The price is 6.4% above its 50-day average of $46.78 and 17.8% above its 200-day average of $42.24.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $49.75 | |
| 52-week high | $57.30 | -13.2% |
| 52-week low | $32.24 | +54.3% |
| 50-day average | $46.78 | +6.4% |
| 200-day average | $42.24 | +17.8% |
Price Risk
Over 3 years, its largest fall from a peak was 41.9%.
| Measure | Value |
|---|---|
| 1-year beta | 0.40 |
| Largest fall, 1 year | -41.9% |
| Largest fall, 3 years | -41.9% |
Valuation
Qiagen NV traded at 18.2x earnings at the end of 2025, against a 5-year median of 18.5x and a 10-year median of 19.6x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About QGEN
What is QGEN's 1-year price change?
Qiagen NV's price rose 11.7% over the past 12 months. With dividends included, the 12-month total return was 17.6%.
What is QGEN's 5-year price change?
Qiagen NV's month-end price fell 9.9% over the 5 years through Oct 2026, a compound annual decline of 2.1%. These figures leave out dividends.
What is QGEN's 52-week high and low?
Qiagen NV's 52-week high is $57.30 and its 52-week low is $32.24. Its latest price of $49.75 on Nov 17, 2026 is 13.2% below the high.
What is QGEN's beta?
Qiagen NV's 1-year beta against the S&P 500 is 0.40, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 41.9%.
Is the QGEN chart free?
Yes. Advanced Charting for QGEN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
QGEN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts